Retour

INVENTIVA (EPA:IVA) Results of the votes of the Combined Shareholders’ General Meeting of January 25, 2023

Directive transparence : information réglementée

26/01/2023 08:00

26/01/2023 08:00

Results of the votes of the Combined Shareholders’ General Meeting of...

04/01/2023 22:00

Inventiva announces changes to the clinical development of lanifibranor,...

03/01/2023 08:35

Statement of total voting rights and shares forming the company’s share...

28/11/2022 22:00

Inventiva secures a new patent expanding the IP protection of its lead...

21/11/2022 22:00

Inventiva announces a new Director of the Board of Directors

10/11/2022 22:00

Inventiva reports 2022 Third Quarter Financial Information¹

31/10/2022 08:00

Inventiva provides an update on the development of cedirogant by AbbVie

21/10/2022 22:00

Inventiva announces a scientific presentation at the AASLD The Liver...

21/09/2022 22:40

Inventiva and Sino Biopharm announce licensing and collaboration agreement...

07/09/2022 22:00

Inventiva announces the schedule of publication and presentation of its...

Voir tous les communiqués de INVENTIVA